Detection of E119V and E119I mutations in influenza A (H3N2) viruses isolated from an immunocompromised patient: challenges in diagnosis of oseltamivir resistance.
about
Clinical Implications of Antiviral Resistance in InfluenzaA Novel I221L Substitution in Neuraminidase Confers High-Level Resistance to Oseltamivir in Influenza B VirusesInfluenza neuraminidase inhibitors: antiviral action and mechanisms of resistanceTriple combination antiviral drug (TCAD) composed of amantadine, oseltamivir, and ribavirin impedes the selection of drug-resistant influenza A virusComparison of mutation patterns in full-genome A/H3N2 influenza sequences obtained directly from clinical samples and the same samples after a single MDCK passageA Novel Antiviral Target Structure Involved in the RNA Binding, Dimerization, and Nuclear Export Functions of the Influenza A Virus NucleoproteinHigh-Efficiency Capture of Drug Resistant-Influenza Virus by Live Imaging of Sialidase ActivitySensitive Detection and Simultaneous Discrimination of Influenza A and B Viruses in Nasopharyngeal Swabs in a Single Assay Using Next-Generation Sequencing-Based DiagnosticsResistance to Mutant Group 2 Influenza Virus Neuraminidases of an Oseltamivir-Zanamivir Hybrid Inhibitor.Unique Determinants of Neuraminidase Inhibitor Resistance among N3, N7, and N9 Avian Influenza Viruses.Neuraminidase Mutations Conferring Resistance to Oseltamivir in Influenza A(H7N9) VirusesGenetic analysis of H3N2 avian influenza viruses isolated from live poultry markets and poultry slaughterhouses in Shanghai, China in 2013.Translational research on influenza virus infection using a nonhuman primate model.Novel genotyping and quantitative analysis of neuraminidase inhibitor resistance-associated mutations in influenza a viruses by single-nucleotide polymorphism analysisRethinking approaches to improve the utilization of nucleic acid amplification tests for detection and characterization of influenza A in diagnostic and reference laboratories.Update on influenza diagnostics: lessons from the novel H1N1 influenza A pandemicOseltamivir-resistant influenza A and B viruses pre- and postantiviral therapy in children and young adults with cancer.Combinatorial effect of two framework mutations (E119V and I222L) in the neuraminidase active site of H3N2 influenza virus on resistance to oseltamivirPharmacokinetics of oseltamivir among pregnant and nonpregnant women.Application of a seven-target pyrosequencing assay to improve the detection of neuraminidase inhibitor-resistant Influenza A(H3N2) virusesInfluenza B viruses with mutation in the neuraminidase active site, North Carolina, USA, 2010-11Emergence of H7N9 Influenza A Virus Resistant to Neuraminidase Inhibitors in Nonhuman Primates.Recovery of influenza B virus with the H273Y point mutation in the neuraminidase active site from a human patient.Reduced susceptibility to all neuraminidase inhibitors of influenza H1N1 viruses with haemagglutinin mutations and mutations in non-conserved residues of the neuraminidase.Bioluminescence-based neuraminidase inhibition assay for monitoring influenza virus drug susceptibility in clinical specimens.Emergence of an oseltamivir-resistant influenza A/H3N2 virus in an elderly patient receiving a suboptimal dose of antiviral prophylaxis.Surveillance of antiviral resistance markers in Argentina: detection of E119V neuraminidase mutation in a post-treatment immunocompromised patient.Fitness costs for Influenza B viruses carrying neuraminidase inhibitor-resistant substitutions: underscoring the importance of E119A and H274Y.Deep sequencing: becoming a critical tool in clinical virology.A review of neuraminidase inhibitor susceptibility in influenza strains.Full-Genome Sequences of Influenza H3N2 Virus Strains Isolated from Finnish Patients during the 2012-2013 Epidemic Season.A new role of neuraminidase (NA) in the influenza virus life cycle: implication for developing NA inhibitors with novel mechanism of action.Combating mutations in genetic disease and drug resistance: understanding molecular mechanisms to guide drug design.The I222V neuraminidase mutation has a compensatory role in replication of an oseltamivir-resistant influenza virus A/H3N2 E119V mutantEffect of oseltamivir carboxylate consumption on emergence of drug-resistant H5N2 avian influenza virus in Mallard ducks.Genetic and antigenic characterization of influenza A(H3N2) in Cameroon during the 2014-2016 influenza seasons.A Review of Clinical Influenza A and B Infections With Reduced Susceptibility to Both Oseltamivir and Zanamivir.Impact on antiviral resistance of E119V, I222L and R292K substitutions in influenza A viruses bearing a group 2 neuraminidase (N2, N3, N6, N7 and N9).Sequence diversity of NanA manifests in distinct enzyme kinetics and inhibitor susceptibility.Detection of a transient R292K mutation in influenza A/H3N2 viruses shed for several weeks by an immunocompromised patient.
P2860
Q26782746-4DB7DFA2-7570-43AB-9D60-F6405FE37557Q27683640-DE2943C4-C27B-4B3F-B1BF-228936747475Q28282405-27E477AE-CE58-4E76-908F-14B4ACEA0CD9Q28478637-8082E044-B2C5-4152-9DA5-3F80D27B08B5Q28534776-DCB948B2-5BA1-4D5C-BDF6-8B53CFD48DECQ28546866-28C3E7CA-8B4A-4A0E-9616-1C5C392EFF00Q28552500-2094D3D1-A5E3-4DD8-86A2-5EC2CC006A02Q28554325-45AC6511-13DC-4555-BBFB-FBDEB1BBBFE0Q30151772-66C6C6B3-2F8F-4588-BAF3-FDC93822F5AEQ30202859-C2A96D85-3F01-4EAC-A931-048821618673Q30372421-3932CFA7-49E5-41A6-9CD9-4E8E87643BF9Q30374002-E6177A82-57A1-43F7-8E01-ED4C5461E4D1Q30383873-8DE50784-E497-4EC6-95EA-C4687C61E7DBQ30404485-14F3C3AE-FBAE-4065-B6C5-8E4A7138553EQ30410029-4499F2F7-32F0-47DD-AFC1-4D19368B2217Q30415228-EB0F24EE-4555-499E-AEF0-ED3FB0EB169AQ34759825-0CFDEC6E-E6FC-4B5C-8EC4-8EE84E05E5ECQ35005209-05F810AA-160E-437A-A607-DE4054386B20Q35036389-BF248009-9621-4166-BE27-3C3409CC96F0Q35168895-57C7EC9C-330D-4FD6-92A9-FEDCECC0D132Q35847269-C26243D8-0664-411F-8156-2E12B8ABBEEBQ35860081-98BE06D1-9DB2-4A02-98AF-96C7377A96EAQ36118639-93ED0A3D-3192-4A4D-890A-E2B081D2CABDQ37169942-C2F0E547-ACC5-431C-8E9D-907B2F6D39ACQ37263328-AA461775-189D-4BE2-B4D7-F80A8C0E5424Q37336164-8A8A2EA5-2AE7-435E-927B-213EB621187EQ37487500-96548BB1-FAA8-4A40-9F69-F35F1B9F6E46Q37713074-6E2B05E4-5227-42AA-B582-D7D0549CCDBCQ38226696-A355E245-91F5-4506-A5C7-86EFF8B56AF1Q38258646-12557F11-E719-4914-9847-A3BF76AEEDB5Q38543859-215EB880-1885-41BD-9061-47E21E5BC330Q38802959-5D81DD54-2D69-49C3-A7A0-003F1858B188Q39296374-23D65526-7E39-4398-919E-D2016ABE9F97Q39627833-563845B6-63C8-4F51-9E8E-4B2FC4DCF58FQ40004651-50DB5C4B-A9AD-4595-AA87-552E36B41652Q40055695-B6C05D27-8EAD-4A65-8376-92ED5F0A3EBFQ40065607-0D2C0A0B-1DA8-47A2-9691-D9AFA859CDFFQ40644333-E9228BA8-2513-4A9C-A118-8616A8FCA3E6Q40777377-F1BD1C5F-B833-487F-B1A8-519AC67074EFQ41851833-8682C4D9-367B-4F99-9C37-4218437E06FC
P2860
Detection of E119V and E119I mutations in influenza A (H3N2) viruses isolated from an immunocompromised patient: challenges in diagnosis of oseltamivir resistance.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Detection of E119V and E119I m ...... sis of oseltamivir resistance.
@ast
Detection of E119V and E119I m ...... sis of oseltamivir resistance.
@en
type
label
Detection of E119V and E119I m ...... sis of oseltamivir resistance.
@ast
Detection of E119V and E119I m ...... sis of oseltamivir resistance.
@en
prefLabel
Detection of E119V and E119I m ...... sis of oseltamivir resistance.
@ast
Detection of E119V and E119I m ...... sis of oseltamivir resistance.
@en
P2093
P2860
P356
P1476
Detection of E119V and E119I m ...... sis of oseltamivir resistance.
@en
P2093
Alexander I Klimov
Gail J Demmler-Harrison
Larisa V Gubareva
Margaret Okomo-Adhiambo
Tiffany G Sheu
Varough M Deyde
P2860
P304
P356
10.1128/AAC.01608-09
P407
P577
2010-03-01T00:00:00Z